BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 1838546)

  • 21. Predicting impairment of central vision from dimensions of the optic chiasm in patients with pituitary adenoma.
    Carrim ZI; Reeks GA; Chohan AW; Dunn LT; Hadley DM
    Acta Neurochir (Wien); 2007 Mar; 149(3):255-60; discussion 260. PubMed ID: 17273885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visual acuity and pattern of visual field loss at presentation in pituitary adenoma.
    Ogra S; Nichols AD; Stylli S; Kaye AH; Savino PJ; Danesh-Meyer HV
    J Clin Neurosci; 2014 May; 21(5):735-40. PubMed ID: 24656736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of the non-functioning hypophyseal adenoma].
    Comtois R; Beauregard H; Somma M; Rasio E; Serri O; Aris-Jilwan N; Boucher A; Hardy J
    Union Med Can; 1993; 122(6):482-7. PubMed ID: 7905685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cupped disc. Who needs neuroimaging?
    Greenfield DS; Siatkowski RM; Glaser JS; Schatz NJ; Parrish RK
    Ophthalmology; 1998 Oct; 105(10):1866-74. PubMed ID: 9787356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Visual prognosis in pituitary tumors.
    Jain IS; Gupta A; Khurana GS; Khosla VK
    Ann Ophthalmol; 1985 Jul; 17(7):392-6. PubMed ID: 4037598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term visual changes following pituitary irradiation.
    Movsas B; Movsas TZ; Steinberg SM; Okunieff P
    Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):599-605. PubMed ID: 7558949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Visual outcome of surgically managed pituitary adenomas followed-up at the Yaoundé Central Hospital.
    Njami VA; Epee E; Nguifo Fongang EJ; Bello F; Ekoumelon R; Bukam ED; Sobngwi E; Djientcheu VP
    Br J Neurosurg; 2018 Oct; 32(5):521-527. PubMed ID: 30073855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Monitoring and therapy of patients after surgery of hypophyseal adenoma].
    Vladyková J; Marek J; Fusek I; Cigánek L; Vladyka V
    Cesk Oftalmol; 1987 May; 43(3):195-203. PubMed ID: 3594606
    [No Abstract]   [Full Text] [Related]  

  • 29. An Analysis of Retinal Nerve Fiber Layer Thickness before and after Pituitary Adenoma Surgery and its Correlation with Visual Acuity.
    Iqbal M; Irfan S; Goyal JL; Singh D; Singh H; Dutta G
    Neurol India; 2020; 68(2):346-351. PubMed ID: 32189695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of transsphenoidal hypophysectomy on visual deficit due to a pituitary tumour.
    Blaauw G; Braakman R; Cuhadar M; Hoeve LJ; Lamberts SW; Poublon RM; Singh R; Wijngaarde R
    Acta Neurochir (Wien); 1986; 83(3-4):79-82. PubMed ID: 3812042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endoscopic transsphenoidal pituitary surgery: a single surgeon experience and the learning curve.
    Bokhari AR; Davies MA; Diamond T
    Br J Neurosurg; 2013 Feb; 27(1):44-9. PubMed ID: 22900510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnosis of pituitary tumors from the ophthalmological viewpoint].
    Toppel L; Lorenz-Meyer H; Merté HJ
    Munch Med Wochenschr; 1970 Jan; 112(3):89-94. PubMed ID: 5537883
    [No Abstract]   [Full Text] [Related]  

  • 33. [Surgical treatment for giant pituitary adenomas: the state of visual functions].
    Kadashev BA; Faĭzullaev RB; Kalinin PL; Kutin MA; Shkarubo AN; Alekseev SN; Fomichev DV; Grigor'eva NN; Tropinskaia OF
    Vestn Oftalmol; 2009; 125(2):7-10. PubMed ID: 19517822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Changes in visual and oculomotor impairments after endoscopic endonasal transsphenoidal removal of pituitary adenomas].
    Kalinin PL; Kutin MA; Fomichev DV; Kadashev BA; Grigor'eva NN; Tropinskaia OF; Faĭzullaev RB
    Vestn Oftalmol; 2009; 125(4):23-7. PubMed ID: 19824443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of visual loss associated with pituitary macroadenomas.
    Poon A; McNeill P; Harper A; O'Day J
    Aust N Z J Ophthalmol; 1995 May; 23(2):107-15. PubMed ID: 7546685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integration of surgery with fractionated stereotactic radiotherapy for treatment of nonfunctioning pituitary macroadenomas.
    Paek SH; Downes MB; Bednarz G; Keane WM; Werner-Wasik M; Curran WJ; Andrews DW
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):795-808. PubMed ID: 15708259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term outcomes of visual field defects after indocyanine green-assisted macular hole surgery.
    Yamashita T; Uemura A; Kita H; Nakao K; Sakamoto T
    Retina; 2008 Oct; 28(9):1228-33. PubMed ID: 19430390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnetic resonance imaging after transsphenoidal surgery of clinically non-functional pituitary macroadenomas and its impact on detecting residual adenoma.
    Kremer P; Forsting M; Ranaei G; Wüster C; Hamer J; Sartor K; Kunze S
    Acta Neurochir (Wien); 2002 May; 144(5):433-43. PubMed ID: 12111499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-functioning pituitary adenomas: endocrinological and clinical outcome after transsphenoidal and transcranial surgery.
    Wichers-Rother M; Hoven S; Kristof RA; Bliesener N; Stoffel-Wagner B
    Exp Clin Endocrinol Diabetes; 2004 Jun; 112(6):323-7. PubMed ID: 15216450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haemorrhagic pituitary tumour presenting with unilateral paracentral visual disturbance.
    Gore DM; Angunawela RI; Little BC; Holder GE
    Eye (Lond); 2009 Jul; 23(7):1621-3. PubMed ID: 18806763
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.